drugset / Trial / NCT06671041

Treating Lid Wiper Epitheliopathy

NCT06671041

NaSingle-groupOpen-labelTreatment

Summary

Lid wiper epitheliopathy (LWE) is a relatively new entry into the abundance of clinical ocular surface health signs. LWE was first reported in 2002 as a potential cause for dry eye disease (DED) (Korb et al., 2002). This clinical sign is visualised by everting the eyelid after a dye has been applied and observing the palpebral conjunctiva proximal to the eyelashes

Timeline

Start
2024-05-27
Primary completion
2024-08-14
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Perfluorohexyloctane Unknown

Indications